Drugs / BIC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04143594 | Nov 2019 → Oct 2021 | HIV infectious disease | Gilead Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04143594 ↗ |
| Route | Oral | “bictegravir (BIC) 75 mg tablets once daily orally at Week 28” NCT04143594 ↗ |